Trial Profile
A Multicenter, Randomized, Double-Blind, Efficacy Study of Auriclosene Irrigation Solution on Indwelling Urinary Catheter Patency
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2017
Price :
$35
*
At a glance
- Drugs Auriclosene (Primary)
- Indications Bacterial infections; Catheter infections; Urinary tract infections
- Focus Therapeutic Use
- Sponsors NovaBay Pharmaceuticals
- 19 Sep 2016 Primary endpoint has been met. (Percent flow rate reduction of study catheters at time of removal), as reported in a NovaBay Pharmaceuticals media release.
- 19 Sep 2016 Results published in the Media Release
- 01 Dec 2015 Planned End Date changed from 1 Dec 2016 to 1 Jan 2016 as reported by ClinicalTrials.gov.